CENCORA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 230.1 USD | -1.07% |
|
-0.70% | +12.06% |
| 08/06 | Top law firms in US opioid lawsuits to get hundreds of millions in fees | RE |
| 03/06 | Cencora Insider Sold Shares Worth $419,506, According to a Recent SEC Filing | MT |
Chart calendar Cencora, Inc.
3.4JDWiSJYw06atEgumJVJoeM4B5xz5jf0gD7dl3kjcd8.lqTi50c6tx_j2xdn-9B87ZIVUc0CiFHB4Xe-xTpEPbmu3bTGTS23At3ZOw~518143a7cf49063c37c259f0888b9003
Upcoming events on Cencora, Inc.
Past events on Cencora, Inc.
| 30/05/2024 07:50 pm | Leerink Partners Healthcare Crossroads Conference |
| 09/05/2024 | Détachement de |
| 01/05/2024 06:00 pm | Q2 2024 Earnings Call |
| 01/05/2024 04:00 pm | Q2 2024 Earnings Release |
| 14/03/2024 06:00 pm | Barclays Global Healthcare Conference |
| 13/03/2024 01:30 am | Annual General Meeting |
| 08/02/2024 | Détachement de |
| 31/01/2024 07:00 pm | Q1 2024 Earnings Call |
| 31/01/2024 05:00 pm | Q1 2024 Earnings Release |
| 09/01/2024 04:30 am | JPMorgan Healthcare Conference |
| 10/11/2023 | Détachement de |
| 02/11/2023 06:00 pm | Q4 2023 Earnings Call |
| 02/11/2023 04:00 pm | Q4 2023 Earnings Release |
| 12/09/2023 10:20 pm | Baird Global Healthcare Conference |
| 11/09/2023 06:10 pm | Morgan Stanley Global Healthcare Conference |
| 10/08/2023 | Détachement de |
| 02/08/2023 06:00 pm | Q3 2023 Earnings Call |
| 02/08/2023 04:00 pm | Q3 2023 Earnings Release |
| 11/05/2023 | Détachement de |
| 10/05/2023 09:50 pm | Bank of America Healthcare Conference |
Past dividends on Cencora, Inc.
| 09/05/2024 | Quarterly 0.51 USD |
| 08/02/2024 | Quarterly 0.51 USD |
| 10/11/2023 | Quarterly 0.51 USD |
| 10/08/2023 | Quarterly 0.485 USD |
| 11/05/2023 | Quarterly 0.485 USD |
| 09/02/2023 | Quarterly 0.485 USD |
| 10/11/2022 | Quarterly 0.485 USD |
| 12/08/2022 | Quarterly 0.46 USD |
| 13/05/2022 | Quarterly 0.46 USD |
| 11/02/2022 | Quarterly 0.46 USD |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 179 589 179 269 0.18% | 189 894 188 599 0.69% | 213 989 212 029 0.92% | 238 587 237 913 0.28% | 262 173 259 650 0.97% | 290 309 |
|
EBITDA Million USD | Released Forecast Spread | 2 354 2 365 -0.46% | 2 485 2 481 0.18% | 2 977 2 956 0.72% | 3 553 3 553 0.01% | 3 702 3 678 0.66% | 4 030 |
|
EBIT Million USD | Released Forecast Spread | 2 051 2 057 -0.29% | 2 204 2 200 0.19% | 2 648 2 619 1.13% | 3 163 3 159 0.13% | 3 289 3 283 0.2% | 3 641 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 967 1 213 -20.27% | -5 294 1 299 -507.42% | 2 222 2 391 -7.07% | 2 183 2 537 -13.95% | 2 161 2 058 5.01% | 2 465 |
|
Net income Million USD | Released Forecast Spread | 855 1 006 -14.95% | -3 409 1 777 -291.82% | 1 540 1 601 -3.84% | 1 699 1 950 -12.88% | 1 745 1 769 -1.34% | 2 023 |
|
EPS USD | Released Forecast Spread | 4,04 4,94 -18.18% | -16,7 8,60 -293.56% | 7,39 7,68 -3.78% | 8,04 9,43 -14.77% | 8,53 8,72 -2.13% | 10,2 |
| Announcement Date | 07/11/19 | 05/11/20 | 04/11/21 | 03/11/22 | 02/11/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 57 719 57 255 0.81% | 60 065 59 029 1.76% | 61 174 60 556 1.02% | 62 847 62 774 0.12% | 63 457 60 404 5.05% | 66 947 63 863 4.83% | 68 922 66 135 4.22% | 72 253 69 235 4.36% | 68 414 70 758 -3.31% | 73 568 | 75 768 | 76 632 | 73 031 | 78 732 |
|
EBITDA Million USD | Released Forecast Spread | 1 014 941 7.74% | 854 845 1.08% | 839 841 -0.2% | 834 828 0.72% | 1 033 1 006 2.76% | 927 901 2.91% | 907 904 0.41% | 991 901 9.98% | 1 141 1 102 3.47% | 972 | 960 | 1 043 | 1 191 | 1 041 |
|
EBIT Million USD | Released Forecast Spread | 917 851 7.69% | 756 756 0.04% | 741 739 0.36% | 734 744 -1.41% | 932 902 3.33% | 822 794 3.51% | 801 794 0.86% | 886 791 11.97% | 1 034 997 3.68% | 869 | 852 | 935 | 1 123 | 935 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 728 581 25.33% | 476 569 -16.24% | 382 535 -28.59% | 593 570 4.08% | 512 746 -31.35% | 609 542 12.33% | 446 494 -9.54% | 783 538 45.6% | 467 732 -36.17% | 603 | 592 | 649 | 827 | 684 |
|
Net income Million USD | Released Forecast Spread | 548 567 -3.31% | 407 465 -12.57% | 295 500 -41.07% | 480 520 -7.69% | 435 616 -29.27% | 480 466 3% | 351 423 -17.17% | 602 429 40.3% | 421 587 -28.32% | 499 | 472 | 573 | 713 | 583 |
|
EPS USD | Released Forecast Spread | 2,59 2,68 -3.28% | 1,92 2,20 -12.59% | 1,40 2,45 -42.76% | 2,33 2,40 -3.1% | 2,13 2,90 -26.5% | 2,35 2,30 2.33% | 1,72 2,10 -17.99% | 2,98 2,16 37.69% | 2,09 2,99 -30.14% | 2,59 | 2,55 | 2,92 | 3,58 | 3,01 |
| Announcement Date | 04/05/22 | 03/08/22 | 03/11/22 | 01/02/23 | 02/05/23 | 02/08/23 | 02/11/23 | 31/01/24 | 01/05/24 | - | - | - | - | - |
| 18/06/2024 04:30 pm | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release |
| 27/06/2024 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
| 05/07/2024 | MANI, INC.: Q3 2024 Earnings Release |
| 11/07/2024 10:30 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
| 12/07/2024 | ARJO AB: Q2 2024 Earnings Release |
| 12/07/2024 11:00 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
| 18/07/2024 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
| 18/07/2024 | MEDMIX AG: Q2 2024 Earnings Release |
| 19/07/2024 10:30 am | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
| 23/07/2024 | NEOGEN CORPORATION: Q4 2024 Earnings Release (Projected) |
Past sector events for Cencora, Inc.
| 05/06/2024 03:30 pm | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
| 28/05/2024 02:00 am | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
| 23/05/2024 04:15 pm | MEDTRONIC PLC: Q4 2024 Earnings Release |
| 22/05/2024 10:30 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
| 17/05/2024 01:49 pm | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 11:30 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 15/05/2024 07:30 am | HOYA CORPORATION: Q4 2023 Earnings Release |
| 14/05/2024 10:30 am | AMBU A/S: Q2 2024 Earnings Release |
| 14/05/2024 | HLB CO., LTD.: Q1 2024 Earnings Release |
| 14/05/2024 | TERUMO CORPORATION: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- COR Stock
- Calendar Cencora, Inc.
